NewGene Plans to Offer 454-Based Genetic Testing for UK's NHS, Other Clients by Early 2010 | GenomeWeb

NewGene, a UK-based molecular diagnostics startup, could soon be one of the first European laboratories to provide clinical genetic tests on 454's sequencing platform.

Toward the end of this year or in early 2010, the Newcastle upon Tyne-based company plans to offer the UK's National Health Service and other clients full-gene sequencing tests for several genetic conditions using Roche's 454 Genome Sequencer FLX. It expects to offer these tests at a lower cost and with a faster turnaround than existing providers using Sanger sequencing, NewGene said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.